Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

Imamura, M; Morimoto, T; Egawa, C; Fukui, R; Bun, A; Ozawa, H; Miyagawa, Y; Fujimoto, Y; Higuchi, T; Miyoshi, Y

Miyoshi, Y (reprint author), Hyogo Coll Med, Div Breast & Endocrine Surg, Dept Surg, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.

SCIENTIFIC REPORTS, 2019; 9 ():

Abstract

The efficacy of trastuzumab emtansine (T-DM1) is prolonged for some patients; however, the predictive factors remain unknown. We focused on a peripher......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索